Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | APAF1 | O14727 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL2936298 | 0.89 | FDPS (0.46) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| Trifluoroacetic Acid SCHEMBL358902 | 0.88 | FDPS (0.43) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| Bicarbonate SCHEMBL357949 | 0.87 | FDPS (0.45) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| Acetic Acid SCHEMBL302143 | 0.87 | FDPS (0.45) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| Bicarbonate SCHEMBL15404411 | 0.87 | FDPS (0.45) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| Propionic Acid SCHEMBL508030 | 0.86 | FDPS (0.44) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| Glycolic Acid SCHEMBL2536925 | 0.86 | FDPS (0.44) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| Oxalic Acid SCHEMBL17710444 | 0.86 | SMN1; SMN2 (0.47) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| Acetic Acid SCHEMBL28506136 | 0.84 | FDPS (0.43) | FDPSSMN1; SMN2MEN1APAF1NPC1 | |
| Pyruvate SCHEMBL2518304 | 0.84 | FDPS (0.43) | FDPSSMN1; SMN2MEN1APAF1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559586-B2 | Compositions containing uretdione groups crosslinking at low temperatures | COVESTRO DEUTSCHLAND AG (DE) | 2026-02-24 | — | — | US | claimed |
| CN-115605525-B | Uretdione-containing compositions that crosslink at low temperatures | 科思创德国股份有限公司 | 2025-01-10 | — | — | CN | claimed |
| EP-4157912-B1 | COMPOSITIONS CONTAINING URETDIONE GROUPS CROSSLINKING AT LOW TEMPERATURES | COVESTRO DEUTSCHLAND AG (DE) | 2024-05-22 | — | — | EP | claimed |
| US-20230192941-A1 | COMPOSITIONS CONTAINING URETDIONE GROUPS CROSSLINKING AT LOW TEMPERATURES | COVESTRO DEUTSCHLAND AG (DE) | 2023-06-22 | — | — | US | claimed |
| EP-4157912-A1 | COMPOSITIONS CONTAINING URETDIONE GROUPS CROSSLINKING AT LOW TEMPERATURES | Covestro Deutschland AG (DE) | 2023-04-05 | — | — | EP | claimed |
| CN-115605525-A | Uretdione group-containing compositions which crosslink at low temperatures | 科思创德国股份有限公司（DE） | 2023-01-13 | — | — | CN | claimed |
| WO-2021239678-A1 | COMPOSITIONS CONTAINING URETDIONE GROUPS CROSSLINKING AT LOW TEMPERATURES | COVESTRO DEUTSCHLAND AG (DE) | 2021-12-02 | — | — | WO | claimed |
| US-12559586-B2 | Compositions containing uretdione groups crosslinking at low temperatures | COVESTRO DEUTSCHLAND AG (DE) | 2026-02-24 | — | — | US | disclosed |
| CN-115605525-B | Uretdione-containing compositions that crosslink at low temperatures | 科思创德国股份有限公司 | 2025-01-10 | — | — | CN | disclosed |
| EP-4157912-B1 | COMPOSITIONS CONTAINING URETDIONE GROUPS CROSSLINKING AT LOW TEMPERATURES | COVESTRO DEUTSCHLAND AG (DE) | 2024-05-22 | — | — | EP | disclosed |
| WO-2023119879-A1 | SEPARATION FUNCTION LAYER, SEPARATION MEMBRANE, AND MEMBRANE SEPARATION METHOD | 日東電工株式会社 | 2023-06-29 | — | — | WO | disclosed |
| US-20230192941-A1 | COMPOSITIONS CONTAINING URETDIONE GROUPS CROSSLINKING AT LOW TEMPERATURES | COVESTRO DEUTSCHLAND AG (DE) | 2023-06-22 | — | — | US | disclosed |
| EP-4157912-A1 | COMPOSITIONS CONTAINING URETDIONE GROUPS CROSSLINKING AT LOW TEMPERATURES | Covestro Deutschland AG (DE) | 2023-04-05 | — | — | EP | disclosed |
| US-9011576-B2 | Liquid sorbant, method of using a liquid sorbant, and device for sorbing a gas | DINNAGE PAUL (US) | 2015-04-21 | — | — | US | disclosed |
| EP-2831141-A1 | PROCESS FOR ORGANOCATALYTIC RING-OPENING POLYMERIZATION | BASF SE (DE) | 2015-02-04 | — | — | EP | disclosed |
| WO-2014106578-A1 | CATALYSTS FOR POLYURETHANE COATING COMPOUNDS | BASF SE (DE) | 2014-07-10 | — | — | WO | disclosed |
| WO-2013144056-A1 | PROCESS FOR ORGANOCATALYTIC RING-OPENING POLYMERIZATION | BASF SE (DE) | 2013-10-03 | — | — | WO | disclosed |
| EP-2644635-A1 | Process for organocatalytic ring-opening polymerisation | BASF SE (DE) | 2013-10-02 | — | — | EP | disclosed |
| US-20130253164-A1 | PROCESS FOR ORGANOCATALYTIC RING-OPENING POLYMERIZATION | BASF SE (DE) | 2013-09-26 | — | — | US | disclosed |
| US-20110247494-A1 | LIQUID SORBANT, METHOD OF USING A LIQUID SORBANT, AND DEVICE FOR SORBING A GAS | VTU Holding GmbH. (AT) | 2011-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559586-B2 | Compositions containing uretdione groups crosslinking at low temperatures | URB2, UQCRB, UQCRC2 | FDPS 3376/4885SMN1; SMN2 4159/4885MEN1 2202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.